Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/20009666.2021.1921908 http://scihub22266oqcxt.onion/10.1080/20009666.2021.1921908 34211650!8221146!34211650     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Community+Hosp+Intern+Med+Perspect 2021 ; 11 (4): 470-472 Nephropedia Template TP {{tp|p=34211650|t=2021. Resolution of pulmonary artery thrombosis in patients with moderate COVID-19 disease |pdf=|usr=}}{{34211650}} gab.com Text Resolution of pulmonary artery thrombosis in patients with moderate COVID-19 disease JO: J Community Hosp Intern Med Perspect http://www.kidney.de/pget.php?&tw=1&pmid=34211650 #FOAvip Novel Coronavirus disease (COVID-19) has been widely described as the cause for a proinflammatory and hypercoagulable state. The inflammatory process involving the alveolar vascular endothelium in the respiratory system, is a determining factor for the onset of primary Pulmonary Artery Thrombosis (PAT) even in patients with heparin prophylactic treatment. Little is known about the efficacy of the anticoagulant therapy during the course of PAT caused by COVID-19. In this paper we describe the results obtained in patients with moderate COVID-19 disease, previously threated with prophylactic enoxaparin, who then received full Anticoagulant treatment after diagnosis of PAT. After three months Computed Tomography Pulmonary Angiography demonstrated a complete resolution of the vascular obstructive lesions in all patients, while all the coagulation tests were normal. Twit Text FOAVip Resolution of pulmonary artery thrombosis in patients with moderate COVID-19 disease ????J Community Hosp Intern Med Perspect http://www.kidney.de/pget.php?&tw=1&pmid=34211650 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34211650 #FOAvip English Wikipedia <ref>{{Cite pmid|34211650}}</ref> Resolution of pulmonary artery thrombosis in patients with moderate COVID-19 disease #MMPMID34211650 Zanframundo G; Graziani A; Barbara C; Francesco P; Teresa MM; Cristian C; Pierluigi G; Ludovico D J Community Hosp Intern Med Perspect 2021[Jun]; 11 (4): 470-472 PMID34211650show ga Novel Coronavirus disease (COVID-19) has been widely described as the cause for a proinflammatory and hypercoagulable state. The inflammatory process involving the alveolar vascular endothelium in the respiratory system, is a determining factor for the onset of primary Pulmonary Artery Thrombosis (PAT) even in patients with heparin prophylactic treatment. Little is known about the efficacy of the anticoagulant therapy during the course of PAT caused by COVID-19. In this paper we describe the results obtained in patients with moderate COVID-19 disease, previously threated with prophylactic enoxaparin, who then received full Anticoagulant treatment after diagnosis of PAT. After three months Computed Tomography Pulmonary Angiography demonstrated a complete resolution of the vascular obstructive lesions in all patients, while all the coagulation tests were normal. äResolution of pulmonary artery thrombosis in patients with moderate CO(epmc).pdf DeepDyve Pubget Overpricing